Le Lézard
Classified in: Health, Business
Subject: SRI

Survey: Physician Groups Accelerate Adoption of Medicare's Chronic Care Management Program, While MACRA Awareness Remains Relatively Low


CARY, N.C., June 7, 2017 /PRNewswire/ -- Following a slow start, U.S. physician groups have significantly accelerated their adoption of a key federal program aimed at improving the care of Medicare patients with chronic disease, while they remain relatively in the dark about the details of the 2015 law that the program has come to support.

Smartlink Health Solutions develops integrated healthcare solutions targeting wellness and chronic disease management. Smartlink's MACRA Solution Suite includes end-to-end solutions for Annual Wellness Visits, Value-Based Chronic Care Management, and Referral Management. Smartlink's approach to patient enrollment, operational efficiency, electronic collaboration, and care management enables providers to better coordinate care, improving outcomes. For more information, visit SmartlinkHealth.com. (PRNewsfoto/Smartlink Health Solutions)

Forty-one percent of physician groups have launched a Chronic Care Management (CCM) program that meets the requirements for reimbursement by the Centers for Medicare and Medicaid Management (CMS), according to a national survey by Smartlink Health Solutions (formerly Smartlink Mobile Systems), an innovator in value-based healthcare technology solutions.  That is a 141 percent increase in adoption since Smartlink first asked the question of physician groups in a 2015 survey. 

While CCM awareness and participation has risen, the survey showed that physician group leaders generally lack detailed knowledge of the law that the CCM program supports: the Medicare Access and CHIP Reauthorization Act (MACRA).  Passed by a bipartisan majority in Congress, MACRA consolidates and replaces a number of value-based reimbursement programs, including the Physician Quality Reporting System (PQRS), Meaningful Use and the Value-Based Payment Modifier. Just 19 percent of respondents said they are very familiar or an expert on MACRA, compared with 25 percent who said they had either never heard of it or are very unfamiliar. The majority of respondents fell somewhere in between on the scale awareness.

The online survey tracked the responses of 438 physicians, practice managers, and health system executives who were asked about MACRA and strategies like CCM that can help them meet MACRA's requirements.

The survey's findings should be reassuring for CMS, which launched an education initiative in March to education both physician groups and Medicare beneficiaries on the CCM program. The CCM program is an ambitious effort, launched shortly before the passage of MACRA, to curb the cost of caring for the 34.4 million Americans with two or more chronic diseases such as heart disease and diabetes. Improving care management for poly-chronic patients is a critical facet of the transformation to value based payment models such as MACRA.

The CCM program pays providers a monthly fee for historically unreimbursed services: non-face-to-face patient care between office visits such as coordinating with other health care professionals.  The program can potentially increase revenue for participating physicians by having qualified healthcare professionals spend at least 20 minutes per month monitoring patients diagnosed with two or more chronic conditions. CMS hopes the program will significantly improve the quality of life for patients struggling to self-manage their chronic conditions between episodes and to reduce high hospital readmission rates.

White Paper Available for Download

Smartlink has published a whitepaper with a more detailed analysis of the survey results, which can be downloaded at http://www.smartlinkhealth.com/resource-center/market-research-report-macra-success-strategies/.

Other Key Takeaways from the Survey

"MACRA has created a national competitive dynamic that wasn't there before. Winners in this new healthcare payment era will be those that act quickly to manage both short-term and long-term patient outcomes effectively, while leveraging insurer incentives to achieve better care," said Siu Tong, CEO, Smartlink Health. "High ROI government initiatives such as CCM and AWV are key variables in the value equation. The survey data bears out that while the market is now recognizing the importance of these programs, most clinics lack the resources and expertise to deploy them at a scale that will optimize the impact."

Smartlink Health's MACRA solution suite is designed to help healthcare organizations rapidly achieve clinical integration and deploy wellness and care management programs at scale.  Smartlink's value-based approach to CCM ensures consistent, high quality care across large patient populations, targets quality measures, and identifies opportunities for early clinical intervention to prevent health deterioration and reduce utilization. 

About Smartlink Health Solutions

Smartlink Health Solutions is an innovator in value-based healthcare solutions aimed at wellness and chronic disease management.   Smartlink's MACRA Solution Suite includes end to end solutions for Annual Wellness Visits, Value-Based Chronic Care Management (VBCCM), and Referral Management.  Healthcare providers on disparate EMRs are also able to seamlessly share clinical information and collaborate on care via the Smartlink platform, ensuring the level of coordination necessary for commercial contracting.  Smartlink's unique approach to patient enrollment, operational efficiency, electronic collaboration, and guided care management enables clinical services outsourcing organizations and providers to efficiently coordinate care with their client clinics and provide the highest quality of care to the patients they serve.  For more information, visit SmartlinkHealth.com.

MEDIA CONTACT:
Todd Stein
Amendola Communications
916-346-4213
[email protected]

 

SOURCE Smartlink Health Solutions


These press releases may also interest you

at 09:05
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:00
Today, the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations; the Honourable Patty Hajdu, Minister of Indigenous Services and Minister responsible for FedNor; the Honourable Dan Vandal, Minister of Northern Affairs; and the...

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 07:00
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...



News published on and distributed by: